Updated:
CONMED Corporation
CONMED Corporation was founded decades ago as a medical equipment manufacturer and today operates as a publicly traded company (NYSE: CNMD).
CONMED Corporation
CONMED Corporation was founded decades ago as a medical equipment manufacturer and today operates as a publicly traded company (NYSE: CNMD). Its wealth origin is Wall Street public equity markets, not a single family fortune — the firm reports to shareholders and is governed by a board of directors. The company’s strategy spans multiple surgical specialties including orthopedic, general surgery, and patient monitoring. CONMED’s product portfolio encompasses insufflation systems (AirSeal), soft tissue repair implants (BioBrace, CartiMax), energy devices (PlumeSafe smoke evacuators), and surgical power tools (Hall Power). Geographically, it sells to medical institutions worldwide, with a strong presence in North America, Europe, and Asia. CONMED employs thousands globally but does not disclose the number of investment professionals. It maintains no separate family office vehicles, foundations, or club memberships that are publicly known. In the last 24 months, the company continued to launch new products such as the Y-Knotless Flex anchor and AirSeal iFS insufflator, reflecting ongoing R&D investment (per the firm's website, 2025). What structurally distinguishes CONMED is its status as a publicly traded operating company rather than an investment vehicle — it designs, manufactures, and sells medical devices directly, with capital allocated toward R&D and commercial expansion rather than portfolio management. This corporate structure subjects it to quarterly earnings reporting and SEC disclosures, a governance model distinct from family offices or asset managers.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Utica
Corporate office
Utica, NY, United States
Sector focus
Frequently asked questions
What type of entity is CONMED Corporation?
CONMED Corporation is a publicly traded company (NYSE: CNMD) that designs, manufactures, and sells medical devices — not a family office, asset manager, or investment fund. Its primary business is producing surgical instruments and technologies for hospitals and medical institutions globally.
Does CONMED operate a family office?
No. CONMED Corporation is a publicly traded operating company without a disclosed family office structure. It is governed by a board of directors and reports to public shareholders, unlike a single-family or multi-family office.
What products does CONMED make?
CONMED's product line includes insufflation systems (AirSeal), soft tissue repair implants (BioBrace, CartiMax), energy devices (PlumeSafe smoke evacuators), surgical power tools (Hall Power), and instruments for orthopedic and general surgery. These are sold to medical institutions worldwide.
Where is CONMED headquartered?
CONMED's corporate headquarters is in Utica, New York, United States. The company does not publicly list additional office locations on its website.
Who owns CONMED?
CONMED is publicly traded on the New York Stock Exchange under the ticker CNMD. Its shareholders include institutional investors, mutual funds, and individual investors, rather than a single family or principal.
What investment stages or asset classes does CONMED target?
As an operating company, CONMED does not make external investments. Its capital is allocated internally toward research and development, manufacturing, sales, and marketing of its own medical devices. It does not engage in fund commitments, direct deals, or co-investments.
Does CONMED have any philanthropic or foundation structures?
CONMED does not publicly disclose any separate philanthropic foundation or charitable vehicle. The firm's website does not mention a corporate foundation or giving program.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: